These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16981681)

  • 1. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein interconversions.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated silver, barium and strontium in antlers, vegetation and soils sourced from CWD cluster areas: do Ag/Ba/Sr piezoelectric crystals represent the transmissible pathogenic agent in TSEs?
    Purdey M
    Med Hypotheses; 2004; 63(2):211-25. PubMed ID: 15236778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies.
    Ishikawa K; Kudo Y; Nishida N; Suemoto T; Sawada T; Iwaki T; Doh-ura K
    J Neurochem; 2006 Oct; 99(1):198-205. PubMed ID: 16987247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transmissible spongiform encephalopathies.
    Lasmézas CI
    Rev Sci Tech; 2003 Apr; 22(1):23-36. PubMed ID: 12793772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of prion proteins: physiological and pathological implications.
    Fournier JG; Escaig-Haye F; Grigoriev V
    Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an ultra violet photooxidation of the manganese-loaded/copper-depleted prion protein in the retina initiate the pathogenesis of TSE?
    Purdey M
    Med Hypotheses; 2001 Jul; 57(1):29-45. PubMed ID: 11421622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route.
    Sisó S; Jeffrey M; González L
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):232-46. PubMed ID: 19473292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
    Bastian FO; Fermin CD
    Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal microcrystal pollutants: the heat resistant, transmissible nucleating agents that initiate the pathogenesis of TSEs?
    Purdey M
    Med Hypotheses; 2005; 65(3):448-77. PubMed ID: 15908137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to detect prion protein (PrPres) by immunohistochemistry in striated muscle tissues of animals experimentally inoculated with agents of transmissible spongiform encephalopathy.
    Hamir AN; Miller JM; Cutlip RC
    Vet Pathol; 2004 Jan; 41(1):78-81. PubMed ID: 14715973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP genetics in ruminant transmissible spongiform encephalopathies.
    Goldmann W
    Vet Res; 2008; 39(4):30. PubMed ID: 18284908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains.
    Ersdal C; Goodsir CM; Simmons MM; McGovern G; Jeffrey M
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):259-71. PubMed ID: 19473293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental approaches to TSE prevention via inhibition of prion formation.
    Politopoulou G
    Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.